In re HIV Antitrust Litigation

Filing 851

AMENDED JOINT STIPULATION AND ORDER ON ADOPTION OF PRIOR ORDERS re #849 Order on Stipulation. Re #844 filed by parties had incorrect case number (21-cv-06628); CORRECT CASE NO. IS 3:21-cv-9827. Signed by Judge Edward M. Chen on 1/31/2022. (vla, COURT STAFF) (Filed on 1/31/2022)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26

BERRY SILBERBERG STOKES PC
JOSHUA C. STOKES, State Bar No. 220214
CAROL M. SILBERBERG, State No. 217658
6080 Center Drive, Sixth Floor
Los Angeles, CA 90045
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]
Attorneys for Direct Action Health Plan
Plaintiffs Humana Inc.; Blue Cross and Blue
Shield of Florida, Inc. (d/b/a Florida Blue) and
Health Options, Inc. (d/b/a Florida Blue
HMO); Centene Corporation; Blue Cross and
Blue Shield of South Carolina and BlueChoice
HealthPlan of South Carolina, Inc.; and TripleS Salud, Inc.
Daniel A. Sasse
Joanna M. Fuller
Tiffanie L. McDowell
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, CA 92614
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]
[e-mail]
Kent A. Gardiner (pro hac vice forthcoming)
CROWELL & MORNING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: [phone]
Facsimile: [phone]
[e-mail]
Attorneys for Plaintiff Aetna Inc.; Attorneys for
Humana Inc.; Blue Cross and Blue Shield of
Florida, Inc. (d/b/a Florida Blue) and Health
Options, Inc. (d/b/a Florida Blue HMO);
Centene Corporation; Blue Cross and Blue
Shield of South Carolina and BlueChoice
HealthPlan of South Carolina, Inc.; Health
Care Service Corporation, a Mutual Legal
Reserve Company; and Triple-S Salud, Inc.

Heather M. Burke (SBN 284100)
3000 El Camino Real s
2 Palo Alto Square, Suite 900
Palo Alto, CA 94306-2109
Telephone: [phone]
Facsimile: [phone]
Email: [e-mail]
Attorney for Defendants Gilead Sciences, Inc.,
Gilead Holdings, LLC, Gilead Sciences, LLC,
and Gilead Sciences Ireland UC
DANIEL B. ASIMOW (SBN 165661)
ARNOLD & PORTER KAYE SCHOLER LLP
Three Embarcadero Center, 10th Floor
San Francisco, CA 94111-4024
Telephone: [phone]
Facsimile: 415.471.3400
[e-mail]
Attorneys for Defendants
BRISTOL-MYERS SQUIBB COMPANY &
E. R. SQUIBB & SONS, L.L.C.
Christopher T. Holding (pro hac vice
forthcoming)
GOODWIN PROCTER LLP
100 Northern Avenue
Boston, MA 02210
Telephone: [phone]
Facsimile: [phone]
Email: [e-mail]
Attorneys for Defendant
Teva Pharmaceuticals USA, Inc.
(Additional Counsel for Defendants Listed on
Signature Page)
Paul J. Riehle (SBN 115199)
FAEGRE DRINKER BIDDLE & REATH LLP
[e-mail]
Four Embarcadero Center, 27th Floor
San Francisco, CA 94111
Telephone: [phone]
Attorney for Defendants Janssen R&D Ireland,
Janssen Products, LP and Johnson & Johnson

27
28

(Additional Counsel for Defendants Listed on
Signature Page)
JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

1
2
3
4
5
6
7
IN THE UNITED STATES DISTRICT COURT

8

FOR THE NORTHERN DISTRICT OF CALIFORNIA

9
10

SAN FRANCISCO DIVISION
STALEY, et al.,

11
12
13
14
15
16
17
18

Plaintiffs,
v.
GILEAD SCIENCES, INC., et al.,
Defendants.

Case No. 3:19-cv-02573-EMC
AMENDED
JOINT STIPULATION AND
[PROPOSED] ORDER ON ADOPTION
OF PRIOR ORDERS

Ctrm:
Judge:

5 – 17th Floor
Honorable Edward M. Chen

THIS DOCUMENT RELATES TO :

This Document Relates to: 3:21-cv-09620,
4:21-cv-09621, 3:21-cv-09622, 3:21-cv-09632,
4:21-cv-09634, 3:21-cv-09642, 4:21-cv-09644,
3:21-cv-09645, 5:21-cv-09646, 3:21-cv-09
5:21-cv-09648; No. 21-cv-06628 3:21-cv-9827

19
20
21
22
23
24
25
26
27
28

JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

1

WHEREAS, this Court has entered a number of scheduling orders, including the Amended

2

Case Management and Pretrial Order for Jury Trial in the above-captioned action (the “Staley Action”)

3

(see ECF No. 611), which sets certain deadlines and procedures in that action;

4

WHEREAS, this court has concluded that Aetna Inc., v. Gilead Sciences, Inc., et al., No. 21-

5

cv-06628; Blue Cross and Blue Shield of Florida, Inc. et al v. Gilead Sciences, Inc. et al, Docket No.

6

3:21-cv-09622 (N.D. Cal.); Blue Cross and Blue Shield of Florida, Inc. et al v. Teva Pharmaceuticals

7

USA, Inc., Docket No. 3:21-cv-09632 (N.D. Cal.); Blue Cross and Blue Shield of South Carolina, Inc.

8

et al v. Gilead Sciences, Inc. et al, Docket No. 3:21-cv-09645 (N.D. Cal.); Blue Cross and Blue Shield

9

of South Carolina, Inc. et al v. Teva Pharmaceuticals USA, Inc., Docket No. 4:21-cv-09644 (N.D.

10

Cal.); Centene Corp. v. Gilead Sciences, Inc. et al, Docket No. 3:21-cv-09634 (N.D. Cal.); Centene

11

Corp. v. Teva Pharmaceuticals USA Inc., Docket No. 5:21-cv-09648 (N.D. Cal.); Health Care Service

12

Corporation, a Mutual Legal Reserve Company v. Gilead Sciences, Inc. et al, Docket No. 5:21-cv-

13

09646 (N.D. Cal.); Humana Inc. v. Gilead Sciences, Inc. et al, Docket No. 4:21-cv-09621 (N.D. Cal.);

14

Humana Inc. v. Teva Pharmaceuticals USA Inc., Docket No. 3:21-cv-09620 (N.D. Cal.); Triple-S

15

Salud, Inc., v. Gilead Sciences, Inc. et al, Docket No. 3:21-cv-09647 (N.D. Cal.); and Triple-S Salud,

16

Inc., v. Teva Pharmaceuticals USA Inc., Docket No. 3:21-cv-09642 (N.D. Cal.) (collectively the “New

17

Direct Action Health Plan Actions”) are related to the Staley Action (see ECF No. 798);

18

WHEREAS, the Parties1 (Defendants and New Direct Action Health Plan Plaintiffs,

19

collectively) agree that Defendants shall not be required to respond to the New Direct Action Health

20

Plan Plaintiffs’ Complaints until February 16, 2022, and shall have until and including that date to file

21

their motions to dismiss, motions to compel arbitration, or to otherwise respond;

22

WHEREAS, without admitting any allegations in the Complaint, but for the purposes of this

23

stipulation alone, Defendants agree not to assert any arguments or defenses challenging personal

24

jurisdiction and/or venue in any of the New Direct Action Health Plan Actions, including any actions

25

subsequently remanded to state court.
WHEREAS, the Parties agree to be bound by the terms of the following orders entered in the

26
27
28

1

Aetna Inc. believes its case was improperly removed and intends to promptly move to remand.
Aetna reserves all rights to contest the removal of its action and only agrees to be bound by the terms
of the prior orders in the Staley action if its action is not remanded.
-1JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

1

Staley Action: (1) the Stipulated Protective Order (ECF No. 196); (2) the Stipulated Privilege Order

2

(ECF No. 197); (3) the Stipulation and Order Regarding the Non-Disclosure of Certain Information

3

Regarding Expert Witnesses (ECF No. 198); (4) the Joint Stipulated Protocol for the Discovery of

4

Electronically Stored Information and Hard Copy Documents (ECF No. 245); (5) the Joint Stipulation

5

and Order Regarding Deposition Protocol (ECF No. 467); (6) the Stipulated Supplemental Protective

6

Order (ECF No. 484); and (7) the Joint Stipulation and Order on Deposition Coordination (ECF No.

7

571); and

8

WHEREAS, the Parties agree that, for future filings, parties to the New Direct Action Health

9

Plan Actions shall file all papers on the docket for the Staley Action, No. 3:19-cv-02573-EMC, and not

10

on the dockets for the New Direct Action Health Plan Actions, 3:21-cv-09620, 4:21-cv-09621, 3:21-

11

cv-09622, 3:21-cv-09632, 4:21-cv-09634, 3:21-cv-09642, 4:21-cv-09644, 3:21-cv-09645, 5:21-cv-

12

09646, 3:21-cv-09647, and 4:21-cv-09648, so that for the convenience and clarity of the Court and the

13

parties there is a single Master Docket.

14

THE PARTIES HEREBY STIPULATE, SUBJECT TO COURT APPROVAL THAT:

15

1.

The Master Docket for the Coordinated Actions, including the New Direct Action

16

Health Plan Actions, shall be Staley, et al. v. Gilead Sciences, Inc., et al., No. 3:19-cv-02573-EMC

17

(N.D. Cal).

18

2.

When a pleading is intended to apply to the New Direct Action Health Plan Actions

19

and the Coordinated Actions, this shall be indicated by the words: “This Document Relates to: ALL

20

ACTIONS,” in the caption. When a pleading is intended to apply to fewer than all cases, the case name

21

and this Court’s docket number for each individual case to which the document relates shall appear

22

immediately after the phrase “This Document Relates to:” in the caption.

23
24
25

3.

All papers previously filed in the New Direct Action Health Plan Actions are deemed

to be part of the record in the Staley Action.
4.

The Parties are hereby bound by: (1) the Stipulated Protective Order (ECF No. 196);

26

(2) the Stipulated Privilege Order (ECF No. 197); (3) the Stipulation and Order Regarding the Non-

27

Disclosure of Certain Information Regarding Expert Witnesses (ECF No. 198); (4) the Joint Stipulated

28

Protocol for the Discovery of Electronically Stored Information and Hard Copy Documents (ECF No.
-2JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

1

245); (5) the Joint Stipulation and Order Regarding Deposition Protocol (ECF No. 467); (6) the

2

Stipulated Supplemental Protective Order (ECF No. 484); and (7) the Joint Stipulation and Order on

3

Deposition Coordination (ECF No. 571). New Direct Action Health Plan Plaintiffs shall be deemed as

4

“Plaintiffs” as that term is used to refer to the Plaintiffs collectively as a group in the Joint Stipulation

5

and Order Regarding Deposition Protocol (ECF No. 467) and the Joint Stipulation and Order on

6

Deposition Coordination (ECF No. 571). For purposes of discovery from Teva, the New Direct Action

7

Health Plan Plaintiffs shall be bound by the discovery limits set out in the Joint Stipulation and Order

8

on Adoption of Prior Orders in the Retailer Actions (ECF No. 686), with the exception that, to the

9

extent the New Direct Action Health Plan Plaintiffs contend that they need additional discovery beyond

10

those limits, the parties will meet and confer over what additional discovery, if any, is necessary and

11

appropriate.

12

5.

The Parties shall meet and confer in good faith in an effort to agree upon a scheduling

13

order and deadlines to govern the New Direct Action Health Plan Actions, reasonable deadlines for the

14

purpose of completing discovery of New Direct Action Health Plan Plaintiffs and any additional

15

discovery needs of New Direct Action Health Plan Plaintiffs that do not otherwise impact the overall

16

schedule, and agree to work together to move the New Direct Action Health Plan Actions forward

17

expeditiously and in coordination with the Staley Action.

18

6.

Defendants shall be deemed to have been served with the Complaints in the New

19

Direct Action Health Plan Actions as of the date of this Stipulation and Proposed Order, and Defendants

20

shall have until February 16, 2022, to answer, move, or otherwise respond to the New Direct Action

21

Health Plan Plaintiffs’ Complaints, and as to the Aetna Complaint where Aetna has filed a motion to

22

remand, for their time to answer, move or otherwise respond, Defendants shall have until 30 days after

23

a ruling on Aetna’s motion, or such other time as the parties may agree.

24

It is so stipulated, through counsel of record.

25
Respectfully submitted,

26
27
28

Dated: January 27, 2022

BERRY SILBERBERG STOKES PC
By: /s/ Joshua C. Stokes
-3-

JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

BERRY SILBERBERG STOKES PC
JOSHUA C. STOKES, State Bar No. 220214
CAROL M. SILBERBERG, State No. 217658
6080 Center Drive, Sixth Floor
Los Angeles, CA 90045
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]

1
2
3
4
5
6

Attorneys for Humana Inc.; Blue Cross and Blue Shield
of Florida, Inc. (d/b/a Florida Blue) and Health Options,
Inc. (d/b/a Florida Blue HMO); Centene Corporation;
Blue Cross and Blue Shield of South Carolina and
BlueChoice HealthPlan of South Carolina, Inc.; and
Triple-S Salud, Inc.

7
8
9
10
11

Dated: January 27, 2022

12

By: CROWELL & MORING LLP
/s/ Daniel A. Sasse
Daniel A. Sasse
Joanna M. Fuller
Tiffanie L. McDowell
CROWELL & MORING LLP
3 Park Plaza, 20th Floor
Irvine, CA 92614
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]
[e-mail]

13
14
15
16
17
18
19

Kent A. Gardiner (pro hac vice forthcoming)
CROWELL & MORNING LLP
1001 Pennsylvania Avenue NW
Washington, D.C. 20004
Telephone: [phone]
Facsimile: [phone]
[e-mail]

20
21
22
23
24
25

Dated:

January 27, 2022

WHITE & CASE LLP

26
27
28

By: /s/ Heather M. Burke
Heather M. Burke (SBN 284100)
Jeremy K. Ostrander (SBN 233489)
-4JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

1

3000 El Camino Real
2 Palo Alto Square, Suite 900
Palo Alto, CA 94306-2109
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]

2
3
4
5

Christopher M. Curran (pro hac vice)
Peter J. Carney (pro hac vice)

6

701 Thirteenth Street, NW
Washington, District of Columbia 20005-3807
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]

7
8
9
10

Heather K. McDevitt (pro hac vice)
Bryan D. Gant (pro hac vice)
Kristen O'Shaughnessy (pro hac vice)
Michael E. Hamburger (pro hac vice)
Raj S. Gandesha (pro hac vice)

11
12
13

1221 Avenue of the Americas
New York, New York 10020
Telephone: [phone]
Facsimile: [phone]
[e-mail]
[e-mail]
[e-mail]
[e-mail]
[e-mail]

14
15
16
17
18

Attorneys for Defendants Gilead Sciences, Inc.,
Gilead Holdings, LLC, Gilead Sciences, LLC, and
Gilead Sciences Ireland UC

19
20

Dated:

January 27, 2022

FAEGRE DRINKER BIDDLE & REATH LLP

21
22
23
24
25
26
27
28

By: /s/ Paul J. Riehle
Paul J. Riehle (SBN 115199)
[e-mail]
Four Embarcadero Center, 27th Floor
San Francisco, CA 94111
FAEGRE DRINKER BIDDLE & REATH LLP
Paul H. Saint-Antoine (pro hac vice)
[e-mail]
Joanne C. Lewers (pro hac vice)
[e-mail]
One Logan Square, Ste. 2000
Philadelphia, PA 19103
-5JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

Attorneys for Defendants Janssen R&D Ireland,
Janssen Products, LP and Johnson & Johnson

1
2

Dated:

January 27, 2022

ARNOLD & PORTER KAYE SCHOLER LLP

3
By: /s/ Daniel B. Asimow
ARNOLD & PORTER KAYE SCHOLER LLP
Daniel B. Asimow (SBN 165661)
[e-mail]
Three Embarcadero Center, 10th Floor
San Francisco, CA 94111-4024

4
5
6
7

LAURA S. SHORES (pro hac vice)
JAMES L. COOPER (pro hac vice)
ANNE P. DAVIS (pro hac vice)
ARNOLD & PORTER KAYE SCHOLER LLP
601 Massachusetts Ave., N.W.
Washington, D.C. 20001
Telephone: [phone]
Facsimile: 202.942.4999
Email: [e-mail]
Email: [e-mail]
Email: [e-mail]

8
9
10
11
12
13

Attorneys for Defendants
BRISTOL-MYERS SQUIBB COMPANY &
E. R. SQUIBB & SONS, L.L.C.

14
15

Dated:

January 27, 2022

GOODWIN PROCTER LLP

16
17
18
19
20
21
22

By: /s/ Christopher T. Holding ________________
Christopher T. Holding (pro hac vice forthcoming)
GOODWIN PROCTER LLP
100 Northern Avenue
Boston, MA 02210
Telephone: [phone]
Facsimile: [phone]
Email: [e-mail]
Attorneys for Defendant
Teva Pharmaceuticals USA, Inc.

23
24
25
26
27
28
-6JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC

[PROPOSED] ORDER

1
2
3
4

Based on the stipulation of the parties, and good cause therefore, IT IS HEREBY ORDERED
that the Stipulation is approved.
PURSUANT TO STIPULATION, IT IS SO ORDERED.

5
6

Dated:

January 31, 2022

Hon. Edward M. Chen
United States District Judge

7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-7-

JOINT STIPULATION AND [PROPOSED] ORDER ON ADOPTION OF PRIOR ORDERS
CASE NO: 3:19-CV-02573-EMC